ArticleNeuro-oncology2015
Response to "the epidemiology of glioma in adults: a 'state of the science' review".
Abstract readLetterComment
In one paragraph
Article in Neuro-oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Differentiating tumor recurrence and pseudoprogression in postoperative gliomas using pseudo-continuous arterial spin labeling (pCASL) technique.BMC medical imaging · 2025Article
- CAMK2B Impacts the Proliferation, Invasion, and Migration of Glioma Cells via the Ras/Raf/MEK/ERK Signaling Pathway.Oncology research · 2025Article
- SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.BMC cancer · 2023Article
- Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas.Frontiers in oncology · 2022Article
- Review
- Elevated cellular PpIX potentiates sonodynamic therapy in a mouse glioma stem cell-bearing glioma model by downregulating the Akt/NF-κB/MDR1 pathway.Scientific reports · 2021Article
- [Establishment of a mouse model bearing orthotopic temozolomide-resistant glioma].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021Article
- Ion Channels in Glioma Malignancy.Reviews of physiology, biochemistry and pharmacology · 2021Review
- Meta-Analyses of Splicing and Expression Quantitative Trait Loci Identified Susceptibility Genes of Glioma.Frontiers in genetics · 2021Article
- Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma.Translational oncology · 2021Article
- Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management.Pharmaceutics · 2020Review
- MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy.Biomolecules · 2020Review
- Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells.Cells · 2019Review
- Article
- Overexpression of LACTB, a Mitochondrial Protein That Inhibits Proliferation and Invasion in Glioma Cells.Oncology research · 2019Article
- Genetic variants of SOX9 contribute to susceptibility of gliomas among Chinese population.Oncotarget · 2016Article
- Uses of artificial intelligence in glioma: A systematic review.Medicine internationalArticle
Corrections and comments
- Comment on
- Comment on
Authors and funding
12 authors.
Quinn T OstromCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Luc BauchetCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Faith G DavisCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Isabelle DeltourCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
James L FisherCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Chelsea Eastman LangerCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Melike PekmezciCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Judith A SchwartzbaumCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Michelle C TurnerCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Kyle M WalshCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Margaret R WrenschCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Jill S Barnholtz-SloanCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Q.T.O., J.B.S.); Centre Hospitalo-Universitaire Montpellier and Institut National de la Sante et de la Recherche Medicale, Montpellier, France (L.B.); School of Public Heath, University of Alberta, Edmonton, Canada (F.G.D); International Agency for Research on Cancer, Lyon, France (I.D.); The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio (J.L.F.); Centre for Research in Environmental Epidemiology, Barcelona, Spain (C.E.L, M.C.T.); Universitat Pompeu Fabra, Barcelona, Spain (C.E.L., M.C.T.); C.I.B.E.R Epidemiología y Salud Pública, Barcelona, Spain (C.E.L., M.C.T.); Department of Pathology, University of California, San Francisco School of Medicine, San Francisco, California (M.P.); Department of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio (J.A.S); McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ottawa, Canada (M.C.T); Department of Neurological Surgery, University of California, San Francisco School of Medicine, San Francisco, California (K.M.W., M.R.W.).
Funding
Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Susan M Chang · 2002 to 2026
$57.4MGENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMAR01CA052689 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIENCKE, JOHN K., WRENSCH, MARGARET R. · 1991 to 2015
$20.5MNCI NIH HHS P50 CA097257NCI NIH HHS R01 CA052689World Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
Brain NeoplasmsGliomaHumans
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.